Physician

Scott Benjamin Schneider, M.D.

According to 2025 Medicare claims, Scott Schneider, M.D. (NPI: 1336142926) practices radiation oncology in the Portland-Vancouver-Hillsboro, OR-WA market, with the plurality of this provider's patient population coming from Clark, WA. This provider's primary affiliated billing organization is NORTHWEST CANCER SPECIALISTS PC (NPI: 1407828114; TIN: 931280206) and primary practice location at 98684-6930.

Schneider's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 163 traditional Medicare patients, billed 4,389 HCPCS/CPT codes, and received $428,047 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 281 prescription claims across 98 beneficiaries totaling $4,674 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). 2023 DME data shows 12 claims. Open Payments data shows 3 records totaling $160. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $4,279 and ending at $4,674. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	338	28,741	$509,395
2016	345	29,721	$476,629
2017	207	6,895	$335,568
2018	197	5,219	$576,112
2019	187	3,575	$451,379
2020	156	4,192	$486,166
2021	172	3,329	$410,235
2022	157	3,985	$410,537
2023	154	3,681	$395,351
2024	163	4,389	$428,047

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	63	176	$4,279
2016	50	145	$2,988
2017	66	177	$4,497
2018	72	225	$8,229
2019	55	150	$3,216
2020	60	116	$2,289
2021	74	185	$3,342
2022	74	202	$2,906
2023	69	228	$4,043
2024	98	281	$4,674

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	39	$4,003
2023	N/R	12	$49
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	61	558	$286
77014	Ct guidance for insertion of radiation therapy fields	75	602	$96
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	72	98	$63
84153	Psa (prostate specific antigen) measurement, total	51	145	$18
36415	Insertion of needle into vein for collection of blood sample	54	150	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tamsulosin Hcl	Tamsulosin Hcl	132	6,870	$1,292
Ssd	Silver Sulfadiazine	15	312	$580
Dexamethasone	Dexamethasone	16	320	$395
Oxybutynin Chloride	Oxybutynin Chloride	28	885	$289
Oxycodone Hcl	Oxycodone Hcl	11	85	$97

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$160	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Scott Benjamin Schneider, M.D.?

Tedicare shows public-source Medicare data for Scott Benjamin Schneider, M.D. (NPI 1336142926), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Scott Benjamin Schneider, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Scott Benjamin Schneider, M.D.?

Scott Benjamin Schneider, M.D. is linked to NORTHWEST CANCER SPECIALISTS PC (billing NPI 1407828114) in the available physician profile data.

Does Scott Benjamin Schneider, M.D. have Open Payments data?

Scott Benjamin Schneider, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.